Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effects of HIV and Hepatitis C Virus on the Brain
This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), September 2008
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00494936
  Purpose

This study will determine the effects that HIV and hepatitis C virus have on thinking abilities and whether the viruses affect brain chemistry.


Condition
HIV Infections
Hepatitis C

MedlinePlus related topics: AIDS Hepatitis Hepatitis C
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: HIV/HCV: Neuropsychiatric and Neurophysiological Features

Further study details as provided by National Institute of Mental Health (NIMH):

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 200
Study Start Date: May 2006
Estimated Study Completion Date: July 2009
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIV/HCV
HIV and HCV coninfected
HIV
HIV monoinfected
HIV/HCV nonviremnic
HIV and HCV coinfected with HCV RNA less than 600 copies
HCV
HCV monoinfected with HCV viremia

Detailed Description:

Hepatitis C is a liver disease that is caused by the hepatitis C virus (HCV). It can be successfully treated with 6 to 12 months of medication in both HIV infected and HIV uninfected people. Among HIV infected people, HCV infection is a common co-morbidity, and is more serious when it occurs in this population than others because it leads to liver damage more quickly. HIV is known to cause neurological deficits, and studies suggest that HCV may do so, as well. Knowledge about how to treat these deficits, however, is limited. More information about the nature of the neurological problems and their causes is needed to develop effective treatments. This study will determine the effects that HIV and HCV have on thinking abilities, such as memory, attention, and problem-solving, and whether the viruses affect brain chemistry.

Participants in this 4-year, observational study will undergo a series of tests and interviews. Participants may choose to complete all procedures over 2 days or three appointments. Procedures will include a 20-minute medical interview, a 4-hour neuropsychological evaluation, a 5-minute functional ability questionnaire, blood and urine collection (approximately 15 minutes), and a 1-hour magnetic resonance imaging (MRI) test of the head. The neuropsychological evaluation will test participants' memory, concentration, reasoning, and speed of thinking. All procedures will be completed over approximately 6 hours.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

HIV / HCV Coinfected, HIV moninfected, & HCV monoinfected

Criteria

Inclusion Criteria:

  • CD4 count is greater than 200
  • Hepatitis C infected or uninfected
  • Speaks English

Exclusion Criteria:

  • Currently receiving interferon treatment for hepatitis C
  • History of neurological illness
  • Any psychotic spectrum disorder (e.g., schizophrenia or manic depression/bipolar disorder)
  • History of learning disability
  • History of head injury that entailed a loss of consciousness for more than 30 minutes
  • Any metal in body
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00494936

Contacts
Contact: Elizabeth Ryan, PhD 212-659-8803 elizabeth.ryan@mssm.edu
Contact: Will Rausch, BSc 212-659-9149 william.rausch@mssm.edu

Locations
United States, New York
Mount Sinai School of Medicine Recruiting
New York, New York, United States, 10029-6574
Contact: Elizabeth Ryan, PhD     212-659-8803     elizabeth.ryan@mssm.edu    
Contact: Will Rausch, BSc     212-659-9149     william.rausch@mssm.edu    
Principal Investigator: Elizabeth Ryan, PhD            
Sponsors and Collaborators
Investigators
Principal Investigator: Elizabeth Ryan, PhD Mount Sinai School of Medicine
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Publications:
Responsible Party: Mount Sinai School of Medicine ( Elizabeth Ryan )
Study ID Numbers: K23 MH71181, DAHBR 9A-ASNM
Study First Received: June 28, 2007
Last Updated: September 19, 2008
ClinicalTrials.gov Identifier: NCT00494936  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
HIV
HCV
Treatment Naive
Treatment Experienced
HIV and HCV Coinfection

Study placed in the following topic categories:
Virus Diseases
Hepatitis
Liver Diseases
Sexually Transmitted Diseases, Viral
Digestive System Diseases
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Hepatitis, Viral, Human
Hepatitis C
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Flaviviridae Infections
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 30, 2009